Weapon Payloads for Bulk Chemical and Biological Agent Neutralization
Small Business Information
P.O. Box 5148, Huntsville, AL, 35814
Atris Ray III
President and CEO
President and CEO
AbstractOBJECTIVE: To provide new and innovative conventional weapon concepts that can neutralize (e.g., kill or decompose) large quantities of containerized chemical and biological warfare agents in a non-permissive environment with no intentional agent release, minimizing collateral effects. DESCRIPTION: For offensive operations, current conventional weapons rely on blast and fragmentation as their primary mechanism to defeat chemical and biological targets. Unfortunately, these same mechanisms can create large and unacceptable consequences through the release of hazardous and toxic materials into the environment. A preferred solution to this problem is the ability to neutralize large quantities of chemical and biological warfare agents within their storage containers and warheads, rendering the agents ineffective to the adversary. This type of capability is envisioned to directly transfer the neutralizing energy, environment, or materials into the containers with no intentional release of the agents. No intentional release of the agents in turn basically negates any potential collateral effects issues. It should be noted that ionizing radiation technologies for bulk neutralization have shown promise in this area, but are beset with potential political and legal issues, as wells as create additional collateral damage concerns. Consequently, alternative conventional technologies are sought that cannot only neutralize large quantities of chemical and biological agents, but are also robust against a wide variety of agent types and can easily be integrated into weapon systems. It is expected that proposed technologies may run the gamut in terms of time and distances to neutralize, and effective performance may be limited to certain building environments. Note this solicitation does not address demilitarization operations, although proposed concepts may be based on similar technologies. PHASE I: Phase I must develop a potential weapon payload conceptual design(s) and its method to neutralize bulk quantities of chemical and biological warfare agents. Concept(s) effectiveness will be proven through modeling and simulation against specific agents and containers stored in both production facilities and storage facilities. The design concept should be benchmarked with data that validates its underlying assumptions. A clear Phase I to Phase II decision point must be part of the final delivery in Phase I along with a roadmap that takes the program through Phase III. PHASE II: Phase II must develop a prototype payload capable of neutralizing chemical and biological warfare agents in typical containers and demonstrate and evaluate the prototype payload against bulk stored biological simulants and measure its effectiveness. The final report must clearly demonstrate how this concept will be made into a fieldable system with a complete discussion of the design tradeoffs required to make this system a viable system for field use. Potential partners for production and future use of the developed technology along with a clear Phase II to Phase III decision point must be included along with a roadmap that takes the program through Phase III. PHASE III DUAL USE APPLICATIONS: Potential dual use applications of this technology include uses by the Center for Disease Control (CDC), Department of Homeland Security, or first responders for industrial accidents, contagious outbreak or toxic spill decontamination needs, and homeland security situations. Technologies may also have dual uses for demilitarization or elimination operations. REFERENCES: 1. National Military Strategy to Combat Weapons of Mass Destruction, Chairman of the Joint Chiefs of Staff, February 13, 2006, www.defenselink.mil/pdf/NMS-CWMD2006.pdf
* information listed above is at the time of submission.